{"id":457914,"date":"2021-03-15T14:24:14","date_gmt":"2021-03-15T18:24:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=457914"},"modified":"2021-03-15T14:24:14","modified_gmt":"2021-03-15T18:24:14","slug":"genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/","title":{"rendered":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd."},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK and SAN DIEGO, March  15, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x7JYeWlxNKJKTTv9zIV6vRNIitjUCqfmnZULnq0s6A-nWaOPqbbaV8p2Gxy5m2r6Ccz2g2M7isqxpqwNkIbWxBYULQ0hp0EtLZrBxQyyUHdUtNqioJSGPNhjzaejrAUp\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Wolf Haldenstein Adler Freeman &amp; Herz LLP<\/a> announces that it is investigating GenMark Diagnostics (\u201cGenMark\u201d) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark\u2019s agreement to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share.<\/p>\n<p align=\"justify\">If you currently hold shares of GenMark, please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ejBg2AD5hw_WkycL2EOG8Q_Ji2sVOpPwGZnswYW1wQJsBbqbqLVFLYb_5I_L8y9CAynyGlTz63BK7-4EWXbtOA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">gstone@whafh.com<\/a>.<\/p>\n<p align=\"justify\">Wolf Haldenstein Adler Freeman &amp; Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.<\/p>\n<p align=\"justify\">If you wish to discuss this investigation or have any questions regarding your rights and interests in this matter, please immediately contact <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=x7JYeWlxNKJKTTv9zIV6vT43COO-ZkhOzrJ6yATwxZwaXsHcohuVQ4PbDQK2S27sXJrMEk_zQM2Lm4DdaELUGg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Wolf Haldenstein<\/a> by telephone at (800) 575-0735, via e-mail at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qViRIzZbsbCEBfb-7YZD8xXdZKMh48c9Y6DNK6a1Ez3Gxmm0tki1E_p6gwVAXJH_ATP42sI1VUbrRVNQP9MHD6ryPi6Vr6Q1f5JcjlBfCq8=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">classmember@whafh.com<\/a>, or visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RTt29uJwtXoHJAgojgvpLTw1NtV96-cMnpPYjF4d21Nf9WTJq6TemMs67--kH1NL2Ma0V7CrHEvjDwQ6oicUX171q70t5xGqqoz5YDDeVVk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.whafh.com<\/a>. <\/p>\n<p align=\"justify\">Contact:<\/p>\n<p align=\"justify\">Wolf Haldenstein Adler Freeman &amp; Herz LLP <br \/>Gregory Stone, Director of Case and Financial Analysis<br \/>Kevin Cooper, Esq.<br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ejBg2AD5hw_WkycL2EOG8aQ0BFsWfR8-3nmvZmRHKE1EnC3UOlmOlT7ktovA9MQa_ZMiCWDP0q8OqyRbXX59hw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">gstone@whafh.com<\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qViRIzZbsbCEBfb-7YZD8xXdZKMh48c9Y6DNK6a1Ez21ryN2Acq_BWECtEJxAVwRssPh-7nDzu1dRn-V2keCPFaA93_wS0t54u3YIZaWItI=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">classmember@whafh.com<\/a><br \/>Tel: (800) 575-0735 or (212) 545-4774<\/p>\n<p align=\"justify\">Attorney Advertising. Prior results do not guarantee or predict a similar outcome.<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/2e67aa17-b305-46d1-b053-94466e32ac3b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK and SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that it is investigating GenMark Diagnostics (\u201cGenMark\u201d) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark\u2019s agreement to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share. If you currently hold shares of GenMark, please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com. Wolf Haldenstein Adler Freeman &amp; Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-457914","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK and SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that it is investigating GenMark Diagnostics (\u201cGenMark\u201d) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark\u2019s agreement to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share. If you currently hold shares of GenMark, please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com. Wolf Haldenstein Adler Freeman &amp; Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys &hellip; Continue reading &quot;GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-15T18:24:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.\",\"datePublished\":\"2021-03-15T18:24:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/\"},\"wordCount\":271,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/\",\"name\":\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=\",\"datePublished\":\"2021-03-15T18:24:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/","og_locale":"en_US","og_type":"article","og_title":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk","og_description":"NEW YORK and SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) &#8212; Wolf Haldenstein Adler Freeman &amp; Herz LLP announces that it is investigating GenMark Diagnostics (\u201cGenMark\u201d) (NASDAQ: GNMK) regarding possible breaches of fiduciary duties and other violations of law related to GenMark\u2019s agreement to be acquired by F. Hoffman La-Roche Ltd. Under the terms of the merger, GenMark shareholders will receive $24.05 per share. If you currently hold shares of GenMark, please call Gregory Stone at (800) 575-0735 or (212) 545-4774, or email to gstone@whafh.com. Wolf Haldenstein Adler Freeman &amp; Herz LLP has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys &hellip; Continue reading \"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-15T18:24:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd.","datePublished":"2021-03-15T18:24:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/"},"wordCount":271,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/","name":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=","datePublished":"2021-03-15T18:24:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE5MDMwNSM0MDY0OTQ1IzIwMTc2NzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genmark-diagnostics-investigation-alert-wolf-haldenstein-adler-freeman-herz-llp-is-investigating-the-genmark-diagnostics-acquisition-by-f-hoffman-la-roche-ltd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GENMARK DIAGNOSTICS INVESTIGATION ALERT: Wolf Haldenstein Adler Freeman &amp; Herz LLP is investigating the GenMark Diagnostics acquisition by F. Hoffman La-Roche Ltd."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/457914","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=457914"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/457914\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=457914"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=457914"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=457914"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}